TREM2 and neoplasm: Across cohorts, TREM2+ tumour-associated macrophages (TAMs) accumulate within tumours, correlate with worse outcomes, and exhibit ligand–receptor programmes that recruit Tregs and dampen cytotoxic T-cell function [11,35,36,37].